Researchers at Israel’s Ben-Gurion University have discovered molecules in corals that prevent bacteria from making the biofilm that connects them. This disrupts their communication, weakening infections and enhancing antibiotic effectiveness without harming beneficial microbiota. https://www.bgu.ac.il/en/news-and-articles/coral-derived-molecules-disrupt-bacterial-communication/ https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-025-02234-7

Israel’s BrainsWay reported success in the trial of its accelerated Deep TMS protocol on 104 patients suffering from Major Depressive Disorder (MDD). Both programs of accelerated (10mins) and standard (20 mins) treatment sessions had very high response rates, remission rates, … Continue reading →

The US FDA has approved SELARSDI that Israel’s Teva has developed with Europe’s Alvotech. SELARSDI is a biosimilar (see here previously) to the costly branded Stelara. It treats adult and pediatric psoriatic arthritis and plaque psoriasis, as well as Crohn’s … Continue reading →

Israel’s Lembas (named after elves bread in the movie Lord of the Rings) has developed the GLP-1 Edge dietary supplement. It contains a bioactive peptide that triggers the body’s secretion of GLP-1 and other gut hormones that regulate appetite and … Continue reading →

Israelis have developed many digital platforms to aid mental health. They include Kai.ai, physiological approaches from Calmigo (see here), passive sensing technologies by Behavidence, and the digitally scaled trauma response of NATAL (see here), Israel’s Trauma and Resiliency Centre. https://www.calcalistech.com/ctechnews/article/5nrfwvjte … Continue reading →